Cancer Research4d
Abstract A077: Estrogen-responsive fractions drive the immunosuppressive tumor microenvironment and immunotherapy resistance
1Seoul National University, Seoul, Korea, Republic of.
Cancer Research4d
Abstract A107: Updated results from a study of evalstotug (BA3071), an anti–CTLA-4 conditionally active biologic, in melanoma
Search for other works by this author on: ...
Cancer Research4d
Abstract A102: Assessment of CIT-drugs MoA with in vivo and 3D in vitro imaging
Cancer Immunotherapies (CITs) have shown unprecedented results in improving tumor control. However, many patients are still refractory to treatment. A deeper understanding of CIT-drugs mode of action ...
Cancer Research6d
Investigators Note Hazards of Cutting NIH Indirect Costs
The NIH recently announced a cap of 15% on indirect costs for new grants. This plan has been temporarily blocked in federal court with a hearing scheduled for February 21. If cuts are implemented, ...
Cancer Research4d
Abstract A066: Enhancing breast cancer immunotherapy by modulating the cGAS–STING and CEACAM1–TIM3 pathways in the tumor microenvironment
Immune checkpoint blockade (ICB) therapy has revolutionized cancer treatment, delivering impressive results across various cancers. However, resistance is common, and only a limited number of patients ...
Cancer Research1d
Special Series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI
Publishing in July 2025 to coincide with the AACR Special Conference in Cancer Research: Artificial Intelligence and Machine Learning, the series will continue through December 2025! Technological ...
Cancer Research5d
AACR Manuscript Transfer Service
For authors of Research Articles that have been declined for publication at an AACR journal, the AACR offers the corresponding author the option to easily transfer manuscript files and supporting ...